Dragon III-Phase 3: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer

Clinical trial NCT04384601 · NOT_YET_RECRUITING

Trial details

NCT number: NCT04384601
Sponsor: Ruijin Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Gastric Cancer Neoadjuvant Chemotherapy

Start date: 2021-09-01
Primary completion: 2022-09-01
Enrollment: 246

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.